UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-3 of 3 Help

Filters        
Selected(0)Clear Items/Page:    Sort:
Vascular endothelial growth factor gene transfer therapy for coronary artery disease: A systematic review and meta-analysis Journal article
CARDIOVASCULAR THERAPEUTICS, 2018,Volume: 36,Issue: 5
Authors:  Yuan, Rong;  Xin, Qiqi;  Shi, Weili;  Liu, Wei;  Lee, Simon-M.;  Hoi, Puiman;  Li, Lin;  Zhao, Jun;  Cong, Weihong;  Chen, Keji
View  |  Adobe PDF(849Kb)  |  Favorite  |  View/Download:129/10  |  Submit date:2018/10/30
Angina Pectoris  Angiogenesis Inducing Agents  Coronary Artery Disease  Genetic Therapy  Myocardial Ischemia  Vascular Endothelial Growth Factor  
VEGFR tyrosine kinase inhibitor II (VRI) induced vascular insufficiency in zebrafish as a model for studying vascular toxicity and vascular preservation Journal article
Toxicology and Applied Pharmacology, 2014,Volume: 280,Issue: 3,Page: 408-420
Authors:  Li S.;  Dang Y.Y.;  Oi Lam Che G.;  Kwan Y.W.;  Chan S.W.;  Leung G.P.H.;  Lee S.M.Y.;  Hoi M.P.M.
Favorite  |  View/Download:3/0  |  Submit date:2018/11/06
Cardiovascular Protective Agents  Cardiovascular Toxicity  Vascular Insufficiency  Zebrafish Model  
A novel Danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways Journal article
International Journal of Cardiology, 2013,Volume: 168,Issue: 2,Page: 1349
Authors:  Cui G.;  Shan L.;  Hung M.;  Lei S.;  Choi I.;  Zhang Z.;  Yu P.;  Hoi P.;  Wang Y.;  Lee S.M.Y.
Favorite  |  View/Download:7/0  |  Submit date:2018/10/30
Cardioprotection  Danshensu Derivative  Ischemia  Nrf2  Oxidative Stress